Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
A person named Mauro Macchi has filed a Form 144 notice to sell 500 Class A Ordinary shares of the issuer through UBS Financial Services, Inc. on the NYSE, with an approximate sale date of 01/14/2026. The aggregate market value for this planned sale is listed as 140000.00, and the issuer reports 660432542 shares outstanding.
The securities to be sold were acquired on 10/20/2025 as a stock award from the issuer, with 500 securities acquired on that date. The notice also reports that during the past three months, Mauro Macchi sold an additional 500 Class A Ordinary shares on 01/07/2026 for gross proceeds of 140000.00. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.
Julie Sweet has filed a Form 144 to sell up to 1,694 Class A Ordinary shares. The planned sale is to be executed through UBS Financial Services on the NYSE, with an aggregate market value of
The shares to be sold were acquired as stock awards from the issuer, including 158 shares on
Accenture plc executive Mauro Macchi, Chief Executive Officer-EMEA, reported a planned sale of company stock. On January 7, 2026, he disposed of 500 Class A ordinary shares of Accenture at a price of $280 per share in a transaction coded "S" for sale. The transaction was carried out pursuant to a Rule 10b5-1 trading plan, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Following this sale, Macchi directly beneficially owns 7,623 Class A ordinary shares of Accenture.
A holder of 500 Class A Ordinary shares has filed notice to sell these securities of issuer ACN through UBS Financial Services, Inc. on the NYSE. The planned sale has an aggregate market value of
The seller acquired the 500 shares on
Accenture plc’s general counsel and corporate secretary, Joel Unruch, reported a sale of Class A ordinary shares. On 01/06/2026, he disposed of 1,332 Class A ordinary shares of Accenture at a price of $275 per share, coded as a sale transaction. The filing notes this was a planned disposition made under a Rule 10b5-1 trading plan, which is a pre-arranged program for buying or selling shares.
Following this transaction, Unruch directly beneficially owns 28,207 Accenture Class A ordinary shares. The report is filed as a Form 4 for a single reporting person and reflects his status as an officer of the company.
A holder of ACN stock has filed a notice of proposed sale under Rule 144 for 1,332 Class A Ordinary shares. The planned sale is to be executed through UBS Financial Services, Inc. on the NYSE, with an aggregate market value of 366,300.00 based on the filer’s calculation. The filing lists 660,432,542 shares of this class as outstanding.
The shares to be sold were acquired as stock awards from the issuer, with 541 shares granted on 01/01/2024 and 791 shares granted on 10/20/2025, both shown as non-cash awards. The approximate sale date indicated is 01/06/2026.
Accenture plc executive John F. Walsh, CEO-The Americas, reported multiple Class A ordinary share transactions. On 01/05/2026, he acquired 104 Class A ordinary shares from Accenture at $263.1125 per share under the Accenture Voluntary Equity Investment Program. He also received a grant of 1,656 Class A ordinary shares at a price of $0, also pursuant to the same program.
The filing shows a separate disposition of 420 Class A ordinary shares on 01/05/2026, coded "F", at a price of $263.1125 per share. After these transactions, Walsh beneficially owned 31,207 Class A ordinary shares, held directly.
Accenture plc officer Manish Sharma reported several share transactions involving the company’s Class A ordinary shares. On 01/05/2026, he acquired 70 shares at $263.1125 per share through the Accenture Voluntary Equity Investment Program. He also received a grant of 1,103 shares under the same program at a stated price of $0, reflecting an equity award rather than a market purchase.
On the same date, 256 shares were disposed of at $263.1125 per share with a transaction code "F," indicating shares withheld, typically for tax obligations on equity awards. After these transactions, Sharma beneficially owned 9,788 Class A ordinary shares, all reported as directly held. The filing identifies him as Accenture’s Chief Strategy & Services Officer.
Accenture plc’s Chief Financial Officer, Angie Y. Park, reported several equity transactions in Accenture Class A ordinary shares. On 01/05/2026, she acquired 105 shares at $263.1125 per share through a purchase from Accenture under the Accenture Voluntary Equity Investment Program. She also received a grant of 992 shares at a price of $0 pursuant to the same program.
To cover obligations associated with these awards, a separate transaction on the same date disposed of 140 shares at $263.1125 per share. Following these transactions, she directly beneficially owned 12,980 Class A ordinary shares of Accenture.
Accenture plc’s general counsel and corporate secretary, Joel Unruch, reported several transactions in Class A ordinary shares on 01/05/2026. He purchased 105 shares from Accenture at $263.1125 per share under the Accenture Voluntary Equity Investment Program and received a grant of 1,326 shares under the same program at $0 per share. He also disposed of 375 shares at $263.1125 per share. Following these transactions, he directly beneficially owned 29,539 Class A ordinary shares.